← 返回

全基因组 CRISPR/Cas9 筛选揭示影响肿瘤细胞对 NK 细胞杀伤敏感性的因素

英文原题:Genome-wide CRISPR/Cas9 screen reveals factors that influence the susceptibility of tumor cells to NK cell-mediated killing.

查看英文原题

Genome-wide CRISPR/Cas9 screen reveals factors that influence the susceptibility of tumor cells to NK cell-mediated killing.

PubMed 2025/03/31(内容时间) J Immunother Cancer Q1 · IF 11.7(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

研究概要

在基于 NK 细胞的治疗中,应考虑监测肿瘤细胞表面的 ICAM-1 水平或调控其表达。

中文摘要

自然杀伤(NK)细胞对多种癌细胞具有强效细胞毒活性。过去五十年间,研究者采用多种方法阐明 NK 细胞介导肿瘤控制的复杂分子机制。尽管对 NK 细胞与肿瘤细胞相互作用的认识已显著进展,调控 NK 细胞杀伤肿瘤细胞的因素仍未完全明确,包括 NK 细胞可识别的多种肿瘤配体,以及 NK 细胞清除肿瘤细胞的机制。

本研究将全基因组 CRISPR/Cas9 筛选与功能性细胞毒性试验结合,解析调控结肠腺癌 HCT-116 细胞对 NK 细胞介导细胞毒性敏感性的通路。

对与 NK 细胞共培养后存活的 HCT-116 细胞进行向导 RNA 分布分析,发现 ICAM-1 是 NKp44 介导免疫突触的关键分子;NKp44 是促进 NK 细胞清除 HCT-116 肿瘤细胞的重要激活受体。此外,破坏细胞凋亡或干扰素(IFN)-γ 信号通路相关基因会使肿瘤细胞对 NK 细胞攻击产生耐受。进一步分析发现,NK 细胞来源 IFN-γ 可在体外促进线粒体凋亡,并在体内控制 B16-F10 肺转移。

基于 NK 细胞疗法,应考虑监测肿瘤细胞表面 ICAM-1 水平或调节其表达。研究再次确认,提高 NK 细胞表面 FasL 表达是增强 NK 细胞介导肿瘤杀伤的重要策略,为治疗优化提供另一途径。考虑到 IFN-γ 的扩散特性,研究结果还凸显利用 NK 细胞来源 IFN-γ 增强直接肿瘤杀伤,并通过细胞因子扩散促进旁观者效应的潜力,值得进一步研究。

展开英文摘要原文

Natural killer (NK) cells exhibit potent cytotoxic activity against various cancer cell types. Over the past five decades, numerous methodologies have been employed to elucidate the intricate molecular mechanisms underlying NK cell-mediated tumor control. While significant progress has been made in elucidating the interactions between NK cells and tumor cells, the regulatory factors governing NK cell-mediated tumor cell destruction are not yet fully understood. This includes the diverse array of tumor ligands recognized by NK cells and the mechanisms that NK cells employ to eliminate tumor cells.

In this study, we employed a genome-wide CRISPR/Cas9 screening approach in conjunction with functional cytotoxicity assays to delineate the pathways modulating the susceptibility of colon adenocarcinoma HCT-116 cells to NK cell-mediated cytotoxicity.

Analysis of guide RNA distribution in HCT-116 cells that survived co-incubation with NK cells identified ICAM-1 as a pivotal player in the NKp44-mediated immune synapse, with NKp44 serving as an activating receptor crucial for the elimination of HCT-116 tumor cells by NK cells. Furthermore, disruption of genes involved in the apoptosis or interferon (IFN)- signaling pathways conferred resistance to NK cell attack. We further dissected that NK cell-derived IFN- promotes mitochondrial apoptosis in vitro and exerts control over B16-F10 lung metastases in vivo.

Monitoring ICAM-1 levels on the surface of tumor cells or modulating its expression should be considered in the context of NK cell-based therapy. Furthermore, promoting FasL expression on the NK cell surface is reaffirmed as an important strategy to enhance NK cell-mediated tumor killing, offering an additional avenue for therapeutic optimization. Additionally, considering the diffusion properties of IFN- , our findings highlight the potential of leveraging NK cell-derived IFN- to enhance direct tumor cell killing and facilitate bystander effects via cytokine diffusion, warranting further investigation.

论文信息

作者
Guia S、Fenis A、Baudesson De Chanville C、Galluso J、Medjouel H、Escaliere B、Modelska A、Vienne M
第一作者单位
CIML, Marseille, France.France
通讯作者单位
CIML, Marseille, France narni@ciml.univ-mrs.fr.France
期刊
Journal for immunotherapy of cancer2025 Mar 31
原文标识
PubMed 40164474 · DOI 10.1136/jitc-2024-010699